通过复杂凝聚聚合物对聚米辛E的纳米配方:药物动力学分析
Xiaobao Chen1, Li Liu1, Weidan Wang1
1Scindy Pharmaceutical Co., Ltd., Suzhou Industrial Park, Suzhou 215125, China.
Pharmaceutics
|January 25, 2025
概括
新的纳米配方的多胺E (PME) 使用复杂的同化创建. 这些PME纳米配方可降低毒性,同时保持强大的抗菌活性,对抗耐药性感染.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 聚米辛E (PME) 是一种关键的抗生素,用于治疗多药耐药的格拉姆阴性细菌.
- 毒性是PME治疗的显著剂量限制副作用.
- 需要创新的配方策略,以减轻PME的不良影响,同时保持有效性.
研究的目的:
- 开发使用复杂的协化来降低毒性的PME纳米配方.
- 评估在配方过程中电荷中和是否影响PME的疗效,药理动力学和组织分布.
- 评估开发的 PME 纳米配方的安全性和治疗效果.
主要方法:
- 使用三种负电荷的多离子 (糖八硫酸盐,聚胺酸,氨酸) 与 PME 进行复杂的协.
- 纳米复合物PME-多聚离子的表征,包括大小和多聚分散度指数 (PDI).
- 通过最小抑制度 (MIC) 测定,在小鼠模型中的体内疗效研究,药理动力学分析,组织分布和毒性评估来评估纳米配方.
主要成果:
- 成功形成了PME纳米配方 (<30nm,PDI<0.3) 具有不同的多离子和电荷比.
- 与独立的PME相比,PME纳米配方表现出同等或增强的抗菌活性.
- 在体内研究表明,最大耐受剂量增加,不良反应减少,与独立PME相比,药物动力学概况相似.
结论:
- 复杂的联合化是开发 PME 纳米配方的有效方法.
- 开发的纳米配方减轻了PME固有的正电荷,降低了毒性.
- 这些纳米配方提供了一个有前途的策略,以改善PME的治疗指数治疗耐药感染.
相关概念视频
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
280
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
280
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
691
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
691
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
113
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
113
01:27Factors Influencing Drug Absorption: Drug Dissolution
402
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
402
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173